NP49426a Transition Medicines

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

This public procurement record has 2 releases in its history.

Award

23 Sep 2026 at 01:00

Tender

20 May 2026 at 01:00

Summary of the contracting process

The Common Services Agency, trading as Public Services Delivery Scotland, procured medicines for NHS Scotland through a national supply framework. The eight lots covered RSV immunisation medicines; analgesics, anaesthetics and multiple sclerosis generics; cardiovascular, respiratory and HIV medicines; psychiatry and neurology medicines; cancer medicines; gastrointestinal, endocrine, nutrition and blood medicines; antimicrobial and genitourinary medicines; and skin medicines. Delivery is for NHS Scotland bodies and Integrated Joint Boards across Scotland. This is a goods procurement for pharmaceutical products (CPV 33600000). The framework is organised by medicine category and product line, allowing multiple suppliers to be appointed within categories.

The procurement was run as an open procedure and has reached award stage; contracts are active for six of the eight lots. Awards were made to Merck Sharp & Dohme UK Ltd and Sanofi for RSV immunisations; Crescent Pharma and CST Pharma for analgesics, anaesthetics and multiple sclerosis generics; six suppliers for cardiovascular, respiratory and HIV medicines; 13 suppliers for psychiatry and neurology medicines; six suppliers for cancer medicines; and six suppliers for gastrointestinal, endocrine, nutrition and blood medicines. Contract values respectively are £4,852,424, £2,267,492, £4,334,476, £8,427,628, £2,514,000 and £3,127,716. Contracts were signed between 18 and 29 July 2026. The six contract periods start in August 2026 and end between January 2027 and November 2028. Each lot was evaluated 95% on price and 5% on supply-chain quality. The framework allows up to 50 participants; individual lots may be extended, subject to their stated maximum periods.

This award demonstrates demand across a broad NHS Scotland medicines portfolio, with multi-supplier frameworks divided by therapeutic category and product line. Suppliers positioning for comparable requirements need the ability to supply the relevant medicines at scale and maintain reliable supply chains; supply-chain quality formed a small but explicit part of evaluation alongside price. A current UK marketing authorisation approved by the MHRA is required for every medicine offered. Suppliers and their subcontractors also need valid BS EN ISO 9001 certification or an equivalent, and products must meet MHRA and National Patient Safety Agency packaging and labelling guidance. Bidders must be able to provide product samples on request and submit a climate-change plan describing actions to reduce emissions. The awards show that the buyer appointed multiple suppliers in each awarded category, rather than relying on a single provider.

How relevant is this notice?

Notice Information

Notice Title

NP49426a Transition Medicines

Notice Description

Supply of Transition Medicines to NHS Scotland.

Lot Information

RSV Immunisations

Supply of RSV Monoclonal Antibody Medicines to NHS Scotland. The Authority intends to award this Lot as an unranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Skin Medicines

Supply of skin medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-three (33) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Analgesics, Anaesthetics & MSD Generics

Supply of Analgesics, Anaesthetics & MSD Generics medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-two (32) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Psychiatry and Neurology Medicines

Supply of Psychiatry and Neurology Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-two (22) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cancer Medicines

Supply of Cancer Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of forty-one (41) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Gastrointestinal, Endocrine, Nutrition, Blood Medicines

Supply of Gastrointestinal, Endocrine, Nutrition, Blood Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-six (36) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Antimicrobial and Genitourinary Medicines

Supply of Antimicrobial and Genitourinary Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of fifteen (15) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Cardiovascular, Respiratory, and HIV Medicines

Supply of Cardiovascular, Respiratory, and HIV Medicines to NHS Scotland. The Authority intends to award this Lot as a ranked multi supplier Framework Agreement per product line.

Renewal: The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of thirty-one (31) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000832157
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=SEP565088
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£61,847,781 £10M-£100M
Lots Value
£78,933,168 £10M-£100M
Awards Value
Not specified
Contracts Value
£25,523,736 £10M-£100M

Notice Dates

Publication Date
23 Sep 20261 months ago
Submission Deadline
22 Jun 2026Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Active, Complete
Awards Status
Not Specified
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland

Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland

Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
26
Supplier Names

Merck Sharp & Dohme UK Ltd

Aventis Pharma ltd

Crescent Pharma Limited

CST Pharma Limited

Teva UK Limited

GlaxoSmithKline UK Limited

Focus Pharmaceuticals Ltd

MSN Labs

Zentiva

Viatris UK Healthcare Ltd

STADA UK - Thornton & Ross

Celix Pharma Ltd.

Reig Jofre UK limited

Gerot Lannach UK Ltd

Ranbaxy (UK) Ltd

Colonis Pharma Ltd

Orifarm UK

Janssen-Cilag Ltd

Consilient Health Ltd

Pfizer Ltd

Fresenius Kabi Limited

Dr.Reddy's Laboratories (UK) Limited

Martindale Pharma

Brancaster Pharma Ltd

Bowmed Ibisqus Limited

Novumgen Limited

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...